- Home
- SMSI vs ERNA Comparison
SMSI vs ERNA Comparison
Compare SMSI & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- ERNA
- Stock Information
- Founded
- SMSI 1982
- ERNA 2018
- Country
- SMSI United States
- ERNA United States
- Employees
- SMSI N/A
- ERNA N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- SMSI Technology
- ERNA Health Care
- Exchange
- SMSI Nasdaq
- ERNA Nasdaq
- Market Cap
- SMSI 15.9M
- ERNA 14.2M
- IPO Year
- SMSI 1995
- ERNA N/A
- Fundamental
- Price
- SMSI $0.81
- ERNA $0.18
- Analyst Decision
- SMSI Strong Buy
- ERNA
- Analyst Count
- SMSI 1
- ERNA 0
- Target Price
- SMSI $5.00
- ERNA N/A
- AVG Volume (30 Days)
- SMSI 132.9K
- ERNA 429.2K
- Earning Date
- SMSI 05-07-2025
- ERNA 06-13-2025
- Dividend Yield
- SMSI N/A
- ERNA N/A
- EPS Growth
- SMSI N/A
- ERNA N/A
- EPS
- SMSI N/A
- ERNA N/A
- Revenue
- SMSI $19,378,000.00
- ERNA $535,000.00
- Revenue This Year
- SMSI $31.76
- ERNA N/A
- Revenue Next Year
- SMSI $44.43
- ERNA N/A
- P/E Ratio
- SMSI N/A
- ERNA N/A
- Revenue Growth
- SMSI N/A
- ERNA 365.22
- 52 Week Low
- SMSI $0.52
- ERNA $0.15
- 52 Week High
- SMSI $2.57
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- SMSI 42.90
- ERNA 35.43
- Support Level
- SMSI $0.76
- ERNA $0.16
- Resistance Level
- SMSI $0.86
- ERNA $0.25
- Average True Range (ATR)
- SMSI 0.06
- ERNA 0.02
- MACD
- SMSI -0.00
- ERNA -0.01
- Stochastic Oscillator
- SMSI 34.06
- ERNA 22.22
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.